BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29310088)

  • 21. In utero exposure to poly- and perfluoroalkyl substances (PFASs) and subsequent breast cancer.
    Cohn BA; La Merrill MA; Krigbaum NY; Wang M; Park JS; Petreas M; Yeh G; Hovey RC; Zimmermann L; Cirillo PM
    Reprod Toxicol; 2020 Mar; 92():112-119. PubMed ID: 31323350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental Transfer of Perfluoroalkyl Substances and Associations with Thyroid Hormones: Beijing Prenatal Exposure Study.
    Yang L; Li J; Lai J; Luan H; Cai Z; Wang Y; Zhao Y; Wu Y
    Sci Rep; 2016 Feb; 6():21699. PubMed ID: 26898235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use.
    Berg V; Nøst TH; Huber S; Rylander C; Hansen S; Veyhe AS; Fuskevåg OM; Odland JØ; Sandanger TM
    Environ Int; 2014 Aug; 69():58-66. PubMed ID: 24815340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between prenatal exposure to perfluoroalkyl substances and asthma-related diseases in preschool children.
    Zeng X; Chen Q; Zhang X; Li H; Liu Q; Li C; Ma M; Zhang J; Zhang W; Zhang J; Huang L
    Environ Sci Pollut Res Int; 2019 Oct; 26(29):29639-29648. PubMed ID: 31399834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of prenatal perfluoroalkyl substances exposure on neonatal and child growth.
    Chen MH; Ng S; Hsieh CJ; Lin CC; Hsieh WS; Chen PC
    Sci Total Environ; 2017 Dec; 607-608():669-675. PubMed ID: 28709101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perfluoroalkyl and polyfluoroalkyl substances in cord blood of newborns in Shanghai, China: Implications for risk assessment.
    Wang B; Chen Q; Shen L; Zhao S; Pang W; Zhang J
    Environ Int; 2016 Dec; 97():7-14. PubMed ID: 27770709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between concentrations of perfluoroalkyl substances in human plasma and maternal, infant, and home characteristics in Winnipeg, Canada.
    Workman CE; Becker AB; Azad MB; Moraes TJ; Mandhane PJ; Turvey SE; Subbarao P; Brook JR; Sears MR; Wong CS
    Environ Pollut; 2019 Jun; 249():758-766. PubMed ID: 30933773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal Exposure to Perfluoroalkyl Substances and Birth Outcomes; An Updated Analysis from the Danish National Birth Cohort.
    Meng Q; Inoue K; Ritz B; Olsen J; Liew Z
    Int J Environ Res Public Health; 2018 Aug; 15(9):. PubMed ID: 30149566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal Exposure to Perfluoroalkyl Substances and IQ Scores at Age 5; a Study in the Danish National Birth Cohort.
    Liew Z; Ritz B; Bach CC; Asarnow RF; Bech BH; Nohr EA; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
    Environ Health Perspect; 2018 Jun; 126(6):067004. PubMed ID: 29897723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children.
    Liew Z; Ritz B; Bonefeld-Jørgensen EC; Henriksen TB; Nohr EA; Bech BH; Fei C; Bossi R; von Ehrenstein OS; Streja E; Uldall P; Olsen J
    Am J Epidemiol; 2014 Sep; 180(6):574-81. PubMed ID: 25139206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
    Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
    Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early-Pregnancy Plasma Concentrations of Perfluoroalkyl Substances and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics?
    Sagiv SK; Rifas-Shiman SL; Fleisch AF; Webster TF; Calafat AM; Ye X; Gillman MW; Oken E
    Am J Epidemiol; 2018 Apr; 187(4):793-802. PubMed ID: 29155920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PFOS, PFOA, estrogen homeostasis, and birth size in Chinese infants.
    Wang H; Du H; Yang J; Jiang H; O K; Xu L; Liu S; Yi J; Qian X; Chen Y; Jiang Q; He G
    Chemosphere; 2019 Apr; 221():349-355. PubMed ID: 30641376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal Exposure to Perfluoroalkyl Substances and Behavioral Development in Children.
    Quaak I; de Cock M; de Boer M; Lamoree M; Leonards P; van de Bor M
    Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27213416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of fetal exposure and maternal elimination of perfluoroalkyl substances.
    Zhang T; Qin X
    Environ Sci Process Impacts; 2014 Aug; 16(8):1878-81. PubMed ID: 24882725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring telomere length in mother-newborn pairs in relation to exposure to multiple toxic metals and potential modifying effects by nutritional factors.
    Herlin M; Broberg K; Igra AM; Li H; Harari F; Vahter M
    BMC Med; 2019 Apr; 17(1):77. PubMed ID: 30971237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between maternal per- and polyfluoroalkyl substance exposure and newborn telomere length: Effect modification by birth seasons.
    Pan D; Shao Y; Song Y; Huang D; Liu S; Zeng X; Liang J; Juan Jennifer Tan H; Qiu X
    Environ Int; 2022 Mar; 161():107125. PubMed ID: 35183942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentrations of persistent organic pollutants in maternal and cord blood from the maternal-infant research on environmental chemicals (MIREC) cohort study.
    Fisher M; Arbuckle TE; Liang CL; LeBlanc A; Gaudreau E; Foster WG; Haines D; Davis K; Fraser WD
    Environ Health; 2016 May; 15(1):59. PubMed ID: 27142700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomere length in the two extremes of abnormal fetal growth and the programming effect of maternal arterial hypertension.
    Tellechea M; Gianotti TF; Alvariñas J; González CD; Sookoian S; Pirola CJ
    Sci Rep; 2015 Jan; 5():7869. PubMed ID: 25598199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.